Table 1 Patient’s characteristics
CRI number | Age at liver procedure | Sex | Primary tumor T stage | Primary tumor N stage | Primary tumor M stage | Post primary resection chemotx | Adjuvant chemo before liver resection | Time between resection and chemotx (Days) |
|---|---|---|---|---|---|---|---|---|
CRI 1010 | 60 | F | 3 | 0 | 0 | None | Bevacizumab, Oxaliplatin, Capecitabine | 49 |
CRI 1012 | 53 | M | 3 | 0 | 0 | 5FU + Leukovorin | FOLFOX + avastin | 209 |
CRI 1091 | 60 | M | 3 | 2 | 1 | FOLFOX | FOLFOX | 52 |
CRI 1101 | 47 | F | 3 | 1 | 1 | FOLFOX + avastin | FOLFOX + avastin | 36 |
CRI 1109 | 70 | M | 4 | 1 | 1 | XELOX | XELOX | 52 |
CRI 1102 | 55 | M | 3 | 2 | 1 | FOLFOX + avastin | FOLFOX + avastin | 133 |
CRI 1126 | 60 | F | 3 | 1 | 1 | FOLFOX | FOLFOX + avastin | 487 |
CRI 1129 | 79 | M | Â | Â | Â | None | Capecitabine | 53 |
CRI 1109 | 70 | M | 4 | 1 | 1 | XELOX | XELOX | 123 |
CRI 1208 | 83 | F | 3 | 1 | 0 | XELOX | FOLFIRI + avastin | 103 |
CRI 1109 | 70 | M | 4 | 1 | 1 | n/a | n/a | n/a |
CRI 1197 | 73 | F | Â | Â | 1 | FOLFOX | FOLFOX | 89 |
CRI 1400 | 77 | M | 3 | 0 | 1 | Modified FOLFOX | None | 185 |
CRI 1405 | 33 | F | 3 | 0 | 1 | FOLFOX | FOLFOX | 36 |
CRI 1404 | 50 | F | 3 | 0 | 0 | None | FOLFOX | 35 |
CRI 1513 | 29 | F | 4a | 2b | 0 | FOLFOX | None | None |